Searched for
PHARMACEUTICAL PRICES COMPARISON
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It is quite likely that the news cycle this and the next week will be about the direction of US interest rates and yield. If that turns out...- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
- US drugs site TrumpRx to list 600 generics as Donald Trump targets lower pricesPresident Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Trump pushes 'Most Favoured Nation' plan to slash US drug prices, defends tariff policyPresident Trump announced his plan to lower prescription drug prices in the US through the "Most Favoured Nation" pricing model, aiming to ...
- Trump’s prescription drug price cuts unlikely to hit Indian pharma exports significantly: Crisil RatingsCrisil Ratings reports that President Trump's order to cut US drug prices will have a limited effect on Indian pharma. India's exports, mai...
- Donald Trump's pharma pricing diktat details and how it can be legally challengedPresident Trump signed an executive order aimed at lowering U.S. drug prices to match those of other countries, prompting industry concerns...
- BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution formIt is a more patient-friendly way to tackle prostate cancer. It can help improve patient compliance to a great extent, Badiger said. The co...
- Rally in pharma stocks lifts benchmark indicesLong-term structural growth potential driven by anticipated shortage and price increases prompted investors to shuffle their bets in favour...
- Torrent Pharma shares drop 0.52% as Sensex fallsA total of 5,725 shares changed hands on the counter till 10:25AM (IST)
- Torrent Pharmaceuticals Ltd. shares gain 0.18% as Sensex risesA total of 3,886 shares changed hands on the counter till 01:19PM (IST)
- Three areas pharma companies want Budget to focus onThere are has high expectations from the upcoming Budget, especially for the pharmaceutical industry, said Ranjana Smetacek of OPPI.
- Department of Pharmaceuticals considering price monitoring cellsA scheme of National Pharmaceutical Pricing Authority for setting up price monitoring cell in states" is under initial scrutiny of the Depa...
- SMEs likely to play important role in pharma growth story: ReportThe country's pharmaceutical sector derives its strength from the SME sector, as it forms an essential part of the supply chain for the lar...
- Overseas patented drugs report may seek voluntary price controlThe high-level government committee appointed by the ministry of chemicals & fertilisers for price negotiations of patented medicines is ex...
- Promotional expenses of pharma cos to be cappedThe government is all set to cap the promotional expenses of pharmaceutical companies and limit the price at which new brands are launched ...
- CRAMS cos buck pharma trend, give good returnsThe pharma sector may have underperformed the Sensex , but companies providing contract research and manufacturing services (CRAMS) to glob...
- NPPA has no tool to monitor prices real timeTill early this January, drug price regulator NPPA could force five leading drug makers to cut prices of 11 popular medicines upto a maximu...
Load More
